NCBiotech makes Fast Company's 2025 Most Innovative Companies list The North Carolina Biotechnology Center has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of ...

The Wiggles continue their collabs with country music stars, teaming up with US singer Orville Peck on a track titled Friends of Dorothy. The children’s entertainers have joined forces with ...

The Orville, created by Seth MacFarlane in 2017, honors Star Trek while blending comedy, drama, and space adventures to create its own identity. One intriguing thing about The Orville is that it ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies from importing goods into China. By Alexandra Stevenson Reporting from ...

Colossal Biosciences leaders say the fluffy, golden-haired mice help validate their technique to “de-extinct” species, but outside scientists remain skeptical Sarah Kuta Daily Correspondent A ...

Further details on individual funds will be revealed “upon their final closings,” the firm said. The number of biotech funds raised by venture capital firms peaked in 2021 with 137 new funds bringing ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Thanks to more platforms paying for stand-up than ever, technological advancements that make production significantly cheaper, and social platforms that make promotion easier, we’re in the ...

Startup Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year. The Hayward, California-based drug startup closed on nearly $351 million in a Series D from the likes ...

CHA Biotech Co., South Korea’s leading stem cell therapeutics developer, plans to resume an initial public offering of CHA Healthcare Co., a medical center operator, after combining the affiliate with ...

The deal sees Lilly pay out $9 million upfront plus another $1 million after 15 months to the San Diego biotech, according to Securities and Exchange Commission (SEC) documents filed Feb. 25.

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...